BGI, Inex Create NGS Facility in Singapore to Offer Molecular Genetic Testing | GenomeWeb

NEW YORK (GenomeWeb News) – Women's health diagnostics company Inex Innovations Exchange announced today a partnership with BGI to create a next-generation sequencing facility in Singapore to offer molecular genetic tests.

The first test to be offered will be iGeneScreen, a non-invasive test developed by BGI to detect fetal chromosomal abnormalities. Using a 5 milliliter blood sample from expectant mothers at 12 weeks or later into their pregnancies, the test analyzes fetal DNA in maternal blood for trisomies 21, 18, and 13.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.